期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
H E4在浆液性卵巢癌组织中的表达及与临床病理因素的关系 被引量:4
1
作者 李苁 乌肖林 +4 位作者 姚国栋 邱慧磊 张静波 宋洪涛 耿敬姝 《实用肿瘤学杂志》 CAS 2014年第3期228-232,共5页
目的:探讨人附睾分泌蛋白4( HE4)在浆液性卵巢癌组织中的表达及与临床病理因素之间的关系。方法应用免疫组化的方法检测HE4在140例浆液性卵巢癌组织中的表达情况及与临床病理因素的关系,并联合检测CA125在卵巢癌中的组织学表达情况... 目的:探讨人附睾分泌蛋白4( HE4)在浆液性卵巢癌组织中的表达及与临床病理因素之间的关系。方法应用免疫组化的方法检测HE4在140例浆液性卵巢癌组织中的表达情况及与临床病理因素的关系,并联合检测CA125在卵巢癌中的组织学表达情况,对比HE4与CA125的相关性。结果HE4和CA125在中低分化浆液性卵巢癌组织中的阳性表达率分别为89.76%和81.89%,在高分化者阳性率分别为46.61%和15.38%,中晚期卵巢癌者阳性率为92.44%和83.19%,早期卵巢癌者阳性率为47.62%和33.33%,有盆腔淋巴结转移者阳性率95.65%和84.35%,无盆腔淋巴结转移者40.00%和36.00%,有腹腔种植者阳性率90.00%和87.27%,无腹腔种植者70.00%和33.33%,卵巢癌合并腹水者阳性率89.76%和79.53%,无腹水者为46.15%和38.46%,另外,HE4和CA125在浆液性卵巢癌中的阳性表达率分别为86%和76%,差异均具有统计学意义( P<0.05),两者在卵巢癌的阳性表达上存在相关性(P<0.05)。 HE4和CA125的表达与卵巢癌患者是否绝经和产数无关,(P>0.05)。结论 HE4在浆液性卵巢癌组织中的表达与FIGO分期、肿瘤分化程度、淋巴结有无转移、腹腔有无种植和是否合并腹水有关。 展开更多
关键词 人附睾分泌蛋白4 液性卵巢癌 免疫组化 CA125
下载PDF
Reprogramming of ovarian granulosa cells by YAP1 leads to development of high-grade cancer with mesenchymal lineage and serous features 被引量:2
2
作者 Xiangmin Lv Chunbo He +19 位作者 Cong Huang Guohua Hua Xingcheng Chen Barbara K.Timm Victoria M.Maclin Abigail A.Haggerty Shelly K.Aust Denae M.Golden Bhavana J.Dave Yun-An Tseng Li Chen Hongbo Wang Peichao Chen David L.Klinkebiel Adam R.Karpf Jixin Dong Ronny I.Drapkin Bo R.Rueda John S.Davis Cheng Wang 《Science Bulletin》 SCIE EI CAS CSCD 2020年第15期1281-1296,M0004,共17页
Understanding the cell-of-origin of ovarian high grade serous cancer(HGSC)is the prerequisite for efficient prevention and early diagnosis of this most lethal gynecological cancer.Recently,a mesenchymal type of ovaria... Understanding the cell-of-origin of ovarian high grade serous cancer(HGSC)is the prerequisite for efficient prevention and early diagnosis of this most lethal gynecological cancer.Recently,a mesenchymal type of ovarian HGSC with the poorest prognosis among ovarian cancers was identified by both TCGA and AOCS studies.The cell-of-origin of this subtype of ovarian cancer is unknown.While pursuing studies to understand the role of the Hippo pathway in ovarian granulosa cell physiology and pathology,we unexpectedly found that the Yes-associated protein 1(YAP1),the major effector of the Hippo signaling pathway,induced dedifferentiation and reprogramming of the ovarian granulosa cells,a unique type of ovarian follicular cells with mesenchymal lineage and high plasticity,leading to the development of high grade ovarian cancer with serous features.Our research results unveil a potential cell-of-origin for a subtype of HGSC with mesenchymal features. 展开更多
关键词 Ovarian granulosa cells Cell reprogramming Cell dedifferentiation The Hippo pathway YAP1 oncogene Mesenchymal type of high grade serous CANCER
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部